|Analysis of circulating tumor DNA to monitor metastatic breast cancer|
SJ Dawson, DWY Tsui, M Murtaza, H Biggs, OM Rueda, SF Chin, ...
New England Journal of Medicine 368 (13), 1199-1209, 2013
|Transcriptional activation of miR-34a contributes to p53-mediated apoptosis|
N Raver-Shapira, E Marciano, E Meiri, Y Spector, N Rosenfeld, ...
Molecular cell 26 (5), 731-743, 2007
|Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA|
M Murtaza, SJ Dawson, DWY Tsui, D Gale, T Forshew, AM Piskorz, ...
Nature 497 (7447), 108-112, 2013
|Gene regulation at the single-cell level|
N Rosenfeld, JW Young, U Alon, PS Swain, MB Elowitz
science 307 (5717), 1962-1965, 2005
|Dynamics of the p53-Mdm2 feedback loop in individual cells|
G Lahav, N Rosenfeld, A Sigal, N Geva-Zatorsky, AJ Levine, MB Elowitz, ...
Nature genetics 36 (2), 147-150, 2004
|MicroRNAs accurately identify cancer tissue origin|
N Rosenfeld, R Aharonov, E Meiri, S Rosenwald, Y Spector, M Zepeniuk, ...
Nature biotechnology 26 (4), 462-469, 2008
|Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA|
T Forshew, M Murtaza, C Parkinson, D Gale, DWY Tsui, F Kaper, ...
Science translational medicine 4 (136), 136ra68-136ra68, 2012
|Liquid biopsies come of age: towards implementation of circulating tumour DNA|
JCM Wan, C Massie, J Garcia-Corbacho, F Mouliere, JD Brenton, ...
Nature Reviews Cancer 17 (4), 223, 2017
|Negative autoregulation speeds the response times of transcription networks|
N Rosenfeld, MB Elowitz, U Alon
Journal of molecular biology 323 (5), 785-793, 2002
|Oscillations and variability in the p53 system|
N Geva‐Zatorsky, N Rosenfeld, S Itzkovitz, R Milo, A Sigal, E Dekel, ...
Molecular systems biology 2 (1), 2006.0033, 2006
|The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes|
B Pereira, SF Chin, OM Rueda, HKM Vollan, E Provenzano, HA Bardwell, ...
Nature communications 7 (1), 1-16, 2016
|Variability and memory of protein levels in human cells|
A Sigal, R Milo, A Cohen, N Geva-Zatorsky, Y Klein, Y Liron, N Rosenfeld, ...
Nature 444 (7119), 643-646, 2006
|Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non–small-cell lung carcinoma|
D Lebanony, H Benjamin, S Gilad, M Ezagouri, A Dov, K Ashkenazi, ...
Journal of clinical oncology 27 (12), 2030-2037, 2009
|Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension|
EAB Azizan, H Poulsen, P Tuluc, J Zhou, MV Clausen, A Lieb, C Maniero, ...
Nature genetics 45 (9), 1055-1060, 2013
|Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer|
M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ...
Nature communications 6 (1), 1-6, 2015
|Measuring single-cell gene expression dynamics in bacteria using fluorescence time-lapse microscopy|
JW Young, JCW Locke, A Altinok, N Rosenfeld, T Bacarian, PS Swain, ...
Nature protocols 7 (1), 80, 2012
|Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer|
MKH Hong, G Macintyre, DC Wedge, P Van Loo, K Patel, S Lunke, ...
Nature communications 6 (1), 1-12, 2015
|Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis|
JMJ Weaver, CS Ross-Innes, N Shannon, AG Lynch, T Forshew, ...
Nature genetics 46 (8), 837-843, 2014
|Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis|
RF Schwarz, CKY Ng, SL Cooke, S Newman, J Temple, AM Piskorz, ...
PLoS Med 12 (2), e1001789, 2015
|MiR‐92b and miR‐9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors|
D Nass, S Rosenwald, E Meiri, S Gilad, H Tabibian‐Keissar, ...
Brain pathology 19 (3), 375-383, 2009